Tag: AT-PDN study

Neuralace announces upcoming SEAT trial presentation among other clinical milestones

Neuralace Medical has announced the upcoming clinical study presentation of the SEAT randomised controlled trial (RCT), which is assessing the safety and efficacy of...

Neuralace enrols first patients in AT-PDN study evaluating Axon therapy

Neuralace Medical has announced the commencement of and first patient enrolments in its AT-PDN (Axon therapy and painful diabetic neuropathy) study. The multicentre AT-PDN study...